Form 4: Sage Therapeutics Executive Christopher Benecchi Reports Stock Transactions
SEC Form 4 Filing
Christopher Benecchi, Chief Business Officer of Sage Therapeutics, reports the vesting of performance stock units and a disposition of shares to cover tax obligations.
Summary
- Christopher Benecchi, Chief Business Officer of Sage Therapeutics, reported transactions involving the company's common stock on August 5, 2024.
- These transactions include the vesting of 16,200 shares of common stock due to the achievement of a performance milestone related to previously granted Performance Stock Units (PSUs).
- Benecchi also disposed of 4,755 shares to satisfy tax withholding obligations at a price of $8.96 per share.
- Following these transactions, Benecchi directly owns 18,487 shares of Sage Therapeutics common stock, which includes 1,112 shares purchased through the company's employee stock purchase plan on June 28, 2024.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions, with no inherent positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their transactions in the company's stock.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in insider ownership.
- The vesting of PSUs could be seen as a positive sign for employees, indicating the achievement of company goals.
Key Dates
| Date | Description |
|---|---|
| 02/13/2024 | Reporting person was granted Performance Stock Units (PSUs) to acquire a total of 40,500 shares of common stock. |
| 05/20/2024 | Date of Power of Attorney authorization. |
| 06/28/2024 | Reporting person purchased 1,112 shares under the Sage Therapeutics, Inc. 2014 Employee Stock Purchase Plan. |
| 08/05/2024 | Vesting of 16,200 shares of common stock and disposition of 4,755 shares for tax obligations. |
| 08/07/2024 | Date of Form 4 signature. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.